Enhanced external counterpulsation (EECP) is a noninvasive technique for treatment of symptomatic coronary artery disease in patients not amenable to revascularization procedures. However, the mechanisms underlying the benefits of EECP remain unknown. We hypothesized that decreases in arterial stiffness and aortic wave reflection are a therapeutic target for EECP. Patients with coronary artery disease and chronic angina pectoris were randomized (2:1 ratio) to 35 1-hour sessions of EECP (n ‫؍‬ 28) or sham EECP (n ‫؍‬ 14). Central and peripheral arterial pulse-wave velocity and aortic wave reflection (augmentation index) were measured using applanation tonometry before, and after 17 and 35 1-hour treatment sessions. Wasted left ventricular pressure energy and aortic systolic tension-time index, markers of left-ventricular myocardial oxygen demand, were derived from the synthesized aortic pressure wave. Exercise duration, anginal threshold, and peak oxygen consumption were measured using a graded treadmill test. Central arterial stiffness and augmentation index were decreased after 17 and 35 sessions in the treatment group. Measurements of peripheral arterial stiffness were decreased after 35 sessions in the treatment group. Changes in aortic pressure wave reflection resulted in decreased measurements of myocardial oxygen demand and wasted left ventricular energy. No changes in central or peripheral arterial stiffness were observed in the sham group. Furthermore, measurements of exercise capacity were improved in the EECP group but unchanged in the sham group. In conclusion, EECP therapy decreases central and peripheral arterial stiffness, which may explain improvements in myocardial oxygen demand in patients with chronic angina pectoris after treatment.
Angina pectoris can be caused by decreased coronary blood supply or increased myocardial oxygen demand. Enhanced external counterpulsation (EECP) has been demonstrated to be an effective treatment for patients with angina pectoris. [1] [2] [3] [4] [5] The central hypothesis in most investigations conducted to elucidate the mechanism of action is that EECP may promote coronary angiogenesis and improved myocardial perfusion. 3,4,6 -8 Despite evidence of improved myocardial perfusion in dogs, 6 there is a lack of data that support the central hypothesis in humans. A few small nonrandomized studies have reported that improvements in anginal class and exercise capacity are a result of improved myocardial perfusion. 4, 7, 8 However these findings have not been entirely consistent, 3 thus suggesting extracardiac factors such as altered peripheral vascular function and myocardial oxygen demand may be the therapeutic target for EECP. Therefore, in the present randomized sham-controlled study we tested the hypothesis that EECP treatment would decrease central and peripheral arterial stiffness and improve indexes of myocardial oxygen consumption in patients with coronary artery disease (CAD) and chronic angina pectoris.
Methods
Forty-two consecutive patients with chronic stable angina referred for EECP treatment were randomized in a 2:1 manner into an EECP treatment group or a sham-EECP control group. Patients were enrolled for EECP treatment from November 2004 through June 2009 because they had chronic angina for Ͼ3 months caused by myocardial ischemia in the presence of angiographic multivessel CAD that could not be controlled by a combination of medical therapy, angioplasty/stent, and/or coronary bypass surgery. Patient recruitment was relatively slow because of the singlecenter study design and the nonmetropolitan regional location of Shands Hospital at the University of Florida. The study was approved by the institutional review board of the University of Florida and written informed consent was obtained from all patients. Patient characteristics are presented in Table 1 .
Exclusion criteria included absence of ST-segment depression (1 mm minimum) during exercise testing, coronary artery bypass grafting within previous 3 months or percutaneous coronary intervention in previous 6 months, arrhythmia that would significantly interfere with triggering of the EECP device, symptomatic heart failure and/or left ventricular ejection fraction Ͻ30%, valvular heart disease, implantable cardioverter-defibrillator if triggered within previous 6 months, history of deep vein thrombosis, uncontrolled hypertension, pregnancy, pulmonary congestion, and systemic hypotension.
Patients in the EECP (n ϭ 28) and sham (n ϭ 14) groups received 35 1-hour daily sessions of EECP for 7 consecutive weeks using cuff inflation pressures of 300 and 70 mm Hg, respectively. It was previously determined that 70 mm Hg inflation pressure is adequate to preserve the appearance and feel of EECP application but insufficient to alter blood pressure (BP). 1 The EECP equipment (Vasomedical, Westbury, New York) has been described previously. 1 Data were collected and analyzed at study entry and after 17 and 35 1-hour sessions of EECP or sham EECP. All measurements were performed in a quiet temperature-controlled room (21°C to 23°C) with subjects in a fasting state (10 to 12 hours). Subjects were asked to abstain from caffeine and alcohol for Ն24 hours before vascular measurements. To avoid potential diurnal variations, all measurements were conducted in the morning (7:00 to 9:00 A.M.). 9 All patients discontinued their medications for 12 hours before vascular measurements.
After 15 minutes of supine rest, heart rate and brachial BP measurements were performed in triplicate in the left arm using an automated noninvasive BP cuff (Omron, Inc., Bannockburn, Illinois). An average of the 3 heart rate and BP measurements were used for values at rest. Assessment of arterial wave reflection characteristics was performed noninvasively using the SphygmoCor system (AtCor Medical, Sydney, Australia) described previously. 10 Briefly, peripheral pressure waveforms were recorded from the radial artery at the wrist using applanation tonometry with a highfidelity micromanometer (Millar Instruments, Houston, Texas). A validated generalized transfer function was used to generate the corresponding aortic pressure waveform. Pulse-wave analysis of aortic pressure waveform provided the following key variables of interest: aortic augmentation index, round trip travel time of forward traveling wave from ascending aorta to major reflection site and back, and wasted left ventricular pressure energy, which is a component of extra myocardial oxygen requirement because of early systolic wave reflection. 10, 12 Wasted left ventricular pressure energy was estimated as ([/4] ϫ [augmented pressure ϫ systolic duration of reflected wave] ϫ 1.333), where 1.333 is the conversion factor for millimeters of mercury per second to dynes per square centimeter per second. Augmented pressure is defined as the difference between the first (forward wave) and second systolic shoulders of aortic systolic BP. Additional calculations derived from the synthesized aortic pressure wave were the aortic systolic tension-time index (AsTTI), diastolic pressuretime index, and subendocardial viability ratio. AsTTI is a marker of aortic systolic stress and myocardial oxygen demand and was estimated as the integral of aortic pressure and time during ventricular systole. Diastolic pressure-time index is an indirect indicator of diastolic perfusion and was estimated as the integral of diastolic pressure during ventricular diastole. Subendocardial viability ratio is the ratio of diastolic pressure-time index to TTI and an index of subendocardial perfusion. 13 Only high-quality recordings, defined as an in-device quality index of Ͼ80%, were accepted for analysis.
To determine pulse-wave velocity (PWV), pressure waveforms were recorded at the following 3 sets of sites sequentially-carotid-radial, carotid-femoral, and femoral-dorsalis pedis-using a SphygmoCor Pulse Wave Velocity Vx system and SCOR-2000 6.31 software (AtCor Medical). Pressure waveforms were gated with simultaneous electrocardiography and used to calculate PWV between the respective sites. Foot-to-foot PWV to each peripheral site (radial, femoral, dorsalis pedis) was calculated by determining the delay between the appearance of each pressure waveform foot in the carotid and peripheral sites. 14 The distance between recording sites was adjusted for parallel transmission in the aorta and carotid by correcting for the distance between the suprasternal notch and the carotid. These corrected distances were divided by the respective foot-to-foot transmission delays (carotid-radial, carotidfemoral) to produce PWV. Central PWV (in the mostly elastic aorta) was evaluated using the carotid-femoral data Data are expressed as mean Ϯ SEM. Medical history, gender, and drug regimen data are presented as number of subjects (percent total number within each group). Hypertension was defined as a systolic blood pressure Ͼ140 mm Hg or a diastolic blood pressure Ͼ90 mm Hg. Hyperlipidemia was defined as total cholesterol Ͼ200 mg/dl and/or low-density lipoprotein cholesterol Ͼ130 mg/dl. Baseline characteristics were not significantly different between groups.
and peripheral PWV (in the more muscular conduits) using the femoral-dorsalis pedis and carotid-radial data.
All subjects performed a symptom-limited maximum graded exercise test on a treadmill using a modified Naughton protocol with a metabolic cart for peak oxygen uptake measurements at study entry and after 17 and 35 hours of treatment. Primary measurements included time to angina, total exercise duration, and peak oxygen uptake. The Seattle Angina Questionnaire was used to measure anginal symptomatology. 15 In addition, Canadian Cardiovascular Society anginal classification was determined.
All statistical analyses were performed using SPSS 18.0 for Windows (SPSS, Inc., Chicago, Illinois). Group and continuous variable data are presented as mean Ϯ SEM. All data were tested for normal distribution with the ShapiroWilk test for normality. An alpha level of p Ͻ0.05 was required for statistical significance. Repeated measurements analysis of variance was used to evaluate all continuous dependent variables. When a significant group-by-time interaction was observed, within-group comparisons between time points and between-group comparisons at each time point were performed using Tukey post hoc analysis.
Results
All patients completed the entire EECP or sham treatment sessions. Baseline characteristics for the EECP and sham subjects are presented in Table 1 . EECP and sham groups did not differ with respect to age, gender, height, weight, body mass index, drug therapy, cardiovascular history and/or previous procedures, or cardiovascular risk factors. None of the patients were current smokers. Patients did not change their daily medication or physical activity during the duration of the study. Hemodynamic and pulse-wave analysis results are presented in Table 2 . Baseline (before) hemodynamic and pulse-wave characteristics did not differ between the EECP and sham groups ( Table 2) . Mean arterial pressure and aortic systolic pressure were decreased after 17 sessions of EECP treatment. Systolic, diastolic, and pulse pressures in the periphery (brachial artery) and aorta were decreased after 35 sessions of EECP. There were no significant changes in any of the BP components in the sham group.
Pulse-wave analysis results demonstrated a progressive decrease in aortic augmentation index after 17 (25.8 Ϯ 2.7%) and 35 (23.3 Ϯ 2.7%) sessions of EECP compared to baseline (29.1 Ϯ 2.3%, p Յ0.01; Figure 1 ). Likewise, there was a progressive increase in round trip travel time of pressure wave from the heart to the periphery and back after 17 and 35 sessions of EECP compared to baseline (Table 2 ). In addition, there were decreases in augmented pressure (reflected pressure wave amplitude) and systolic duration of reflected wave after 35 sessions of EECP (Table 2 ). In turn this lead to a substantial decrease in wasted left ventricular pressure energy after 35 sessions of EECP compared to pretreatment values (1,598 Ϯ 233 vs 2,167 Ϯ 372 dyne/ cm 2 /s, p Ͻ0.01; Figure 1 ). AsTTI was also decreased after 35 sessions of EECP (2,071 Ϯ 73 vs 2,287 Ϯ 93, p Ͻ0.05; Figure 2 ). There were no differences in diastolic pressuretime index (3,399 Ϯ 150 vs 3,461 Ϯ 120, p ϭ 0.68; Figure  2 ), but the difference in AsTTI resulted in a significantly higher subendocardial viability ratio (172 Ϯ 8 vs 147 Ϯ 6, p Ͻ0.01; Figure 2 At study entry, exercise parameters did not differ between the EECP and sham groups (Table 3) . EECP treatment led to progressive increases in peak oxygen uptake, total exercise duration, and time to angina after 17 and 35 sessions. No changes in symptom-limited maximum graded exercise test parameters were observed in the sham group. Exercise capacity data before and after treatment (35 sessions) for these patients have been previously published by our group. 16 EECP treatment led to an improvement in anginal function as evidenced by progressive decreases in the number of anginal episodes and nitroglycerin usage per day after 17 and 35 sessions. Consequently, there was an overall improvement in Canadian Cardiovascular Society classification for the EECP group (Table 4) . There were no changes in any measurement of anginal symptom decrease in the sham group. Anginal symptom data before and after treatment (35 sessions) for these patients have been previously published by our group. 16 
Discussion
This is the first randomized sham-controlled study to evaluate the effects of EECP on arterial stiffness and wave reflection characteristics in patients with CAD and refractory angina. The major findings of the present study include (1) EECP decreases central and peripheral arterial stiffness, (2) EECP improves timing and amplitude of aortic wave reflection, and (3) EECP decreases indexes of myocardial oxygen demand.
Our present results demonstrate that aortic stiffness is decreased after short-and long-term EECP treatment (17 and 17 In addition, we found a significant increase in round trip travel time of pressure wave from the heart to the periphery and back, which is inversely related to aortic PWV. 10 In aggregate, our data show that EECP decreases central elastic arterial stiffness in patients with CAD. EECP treatment also decreased peripheral arterial stiffness in the upper (arm) and lower (leg) body, thus suggesting that improvements in arterial stiffness are not limited to vascular regions directly exposed to external mechanical compression. Table 2 . Table 4 Changes in anginal symptoms after enhanced external counterpulsation and sham treatment Table 2 .
Results from the present study also demonstrate improved aortic pressure wave characteristics after EECP. To date, 2 other studies have examined the effect of EECP on aortic pressure wave characteristics. 12, 18 In a pilot uncontrolled study, we previously demonstrated that 34 sessions of EECP resulted in a significant decrease in aortic augmentation index, wasted left ventricular pressure energy, and aortic pressures and an increase in round trip travel time of pressure wave from the heart to the periphery and back. 12 These modifications in wave reflection characteristics were accompanied by an improvement in Canadian Cardiovascular Society class and decreases in average number of anginal episodes. However, Dockery et al 18 found that EECP did not decrease aortic augmentation index in patients with CAD. One potential explanation for the disparity in findings could be that patients in the study by Dockery et al 18 were taking their cardiovascular medications at the time of vascular testing and were likely optimally dilated. In the present study, all baseline and treatment measurements were performed after a Ն12-hour period of with-holding medications to help minimize the acute effects of drug therapy on vascular reactivity. Of clinical importance, improvements in aortic pressure wave characteristics observed in the present study resulted in a substantial decrease in wasted left ventricular pressure energy and estimated myocardial oxygen demand (AsTTI). Wasted left ventricular pressure energy is influenced by systolic duration of the reflected wave and amplitude (augmented pressure) of the reflected wave. In the present study, a decrease in each component contributed to decreased wasted left ventricular pressure energy.
Stiffness of a vessel is commonly thought to be controlled by the distending (mean arterial) pressure and structural elements within the vessel wall. Changes in distending pressure can affect stiffness in large elastic arteries and muscular arteries. Therefore, the possibility exists that changes in arterial stiffness (i.e., PWV) after EECP are caused by the passive effect of a decreased mean arterial pressure. Change in mean arterial pressure after EECP treatment in the present study was not related to changes in carotid-femoral, carotid-radial, or femoral-dorsalis pedis PWV (r ϭ 0.16, p ϭ 0.45; r ϭ 0.29, p ϭ 0.16; and r ϭ 0.06, p ϭ 0.80, respectively). To further address the influence of pressure changes on improvements in PWV after treatment we performed repeated measurements analysis of covariance using change in mean arterial pressure as the covariate. After controlling for change in mean arterial pressure, change in carotid-femoral PWV in the EECP group remained highly significant (p Ͻ0.001). However, changes in carotid-radial (p ϭ 0.15) and femoral-dorsalis pedis (p ϭ 0.08) PWV after treatment were no longer significant. This suggests that improvements in central PWV (i.e., aorta) were independent of BP changes, whereas decreases in peripheral PWV after EECP were partly due to a decrease in pressure.
The smooth muscle of large arteries can influence the distribution of stresses between the compliant elastin and stiffer collagen fibers of a vessel wall and thus alter arterial stiffness. 19 Because circulating and local vasoactive substances influence smooth muscle tone, arterial stiffness may be actively regulated. Along these lines, removal of the vascular endothelium in animals alters large artery stiffness, 20 suggesting that endothelial-derived substances regulate arterial stiffness. Furthermore, substances such as nitric oxide and endothelin-1 have been shown to regulate large artery stiffness in humans. 21, 22 In addition, Nigam et al 23 demonstrated a significant correlation between endothelial function, as assessed by brachial flow-mediated dilatation, and tonometrically measured aortic compliance of the proximal aorta-a more direct index of large artery stiffness.
We recently demonstrated in the same cohort of patients that EECP has a beneficial effect on peripheral artery flowmediated dilation and endothelial-derived vasoactive agents. 16 Therefore, we reasoned that decreases in regional and systemic arterial stiffness after EECP may be explained by improvements in endothelial function. The rapid inflation/deflation cycle of the EECP cuffs causes cyclic strain on leg arteries and systemically increases the rate of shear stress along the arterial wall, which could possibly improve the function of endothelial cells and increase nitric oxide release. We calculate that with a heart rate of 60 beats/min at rest the 35 1-hour EECP sessions cause ϳ150,000 reactive hyperemia episodes (stimuli) in arteries of the lower extremities. Mechanical forces such as arterial shear stress and cyclic strain have been shown to stimulate nitric oxide release. 24, 25 Indeed, improvements in peripheral endothelial function in patients with CAD 26, 27 and endothelial dependent dilation in carotid arteries of pigs 28 have been demonstrated after EECP treatment. Furthermore, EECP has a dose-related sustained effect in stimulating endothelial cell production of nitric oxide and decreasing the release of the potent vasoconstrictor endothelin-1. 7, 29 Together, these studies suggest that EECP treatment improves systemic endothelial function, which likely decreases smooth muscle tone and arterial stiffness and consequently alters wave reflection from peripheral arteries. It is also possible that improvements in the capacitive or reservoir function of the aorta after EECP contributed to the improved aortic wave characteristics. Along these lines, the reservoir function of the aorta and other large elastic arteries contributes to the aortic BP waveform and influences the aortic augmentation index. 30 Our evidence of decreased arterial stiffness and aortic wave reflection after EECP was paralleled by increases in peak oxygen uptake and decreased angina symptoms. Indeed, central artery stiffness is associated with an ischemic threshold during treadmill exercise in patients with CAD. 31 Improvements in wave reflection characteristics and aortic stiffness led to decreases in wasted left ventricular energy and are likely responsible for decreases in myocardial oxygen demand. These improvements in arterial function may explain improvements in anginal class and exercise tolerance commonly observed in patients with CAD after EECP therapy.
